Form 4 for IMVT Immunovant, Inc.
Accepted 2023-04-14 00:00:00 ET · period of report 2023-04-12 · accession 0001764013-23-000044 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-04-14 | 2023-04-12 | IMVT | MIGAUSKY GEORGE V | Dir | A - Grant | $0.00 | +12.5K | 122.5K | +11% | $0 |
| D | 2023-04-14 | 2023-04-12 | IMVT | MIGAUSKY GEORGE V | Dir | A - Grant | $0.00 | +16.3K | 16.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-12 | A | A | 12,523 | $0.00 | 122,508 | D | — | — | (F1) Represents the number of shares underlying restricted stock units awards ("RSUs"). (F2) The RSUs vest in their entirety one year after the date of grant on April 12, 2024, subject to the Reporting Person's continued service to the Issuer as of such date; provided that the Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A. |
| 2 | Derivative | Stock Option (right to buy) | 2023-04-12 | A | A | 16,260 | $0.00 | 16,260 | D | $14.70 · — to 2033-04-12 | 16,260 Common Stock | (F3) The shares underlying the options vest one year after the date of grant on April 12, 2024, subject to the Reporting Person's continuous service to the Issuer as of such date. |